GLP-1 Market
LLY $1270.75 ▼ -1.0% NVO $39.27 ▼ -0.2% PFE $29.72 ▼ -1.3% VKTX $26.64 ▼ -0.3% KLRA $13.16 ▲ +2.1% GPCR $22.41 ▼ -2.1% RHHBY $59.12 ▲ +3.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

VHB937

Company
Novartis Pharmaceuticals
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Oct 21, 2026

Trial details
  • Active, not recruiting NCT NCT06643481

    A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

    Not yet reported Novartis Pharmaceuticals 251 participants Est. completion 2028-07-10 74 sites Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis (ALS)
    View official trial listing →
  • Active, not recruiting NCT NCT07094516

    A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

    Not yet reported Novartis Pharmaceuticals 97 participants Est. completion 2030-12-31 73 sites Stand-alone
    Other conditions: Alzheimer's Disease
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.